25 studies found for:    Open Studies | "Leishmaniasis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Leishmaniasis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis
Conditions: Leishmaniasis;   Leishmaniasis, Mucocutaneous
Intervention: Drug: Miltefosine
2 Recruiting Low Antimonial Dosage in American Mucosal Leishmaniasis
Conditions: Mucosal Leishmaniasis;   Mucocutaneous Leishmaniasis
Intervention: Drug: Meglumine antimoniate
3 Recruiting Miltefosine to Treat Mucocutaneous Leishmaniasis
Conditions: Leishmaniasis, Mucocutaneous;   Cutaneous Leishmaniasis
Intervention: Drug: miltefosine
4 Unknown  Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis
Conditions: Leishmaniasis, Cutaneous;   Leishmaniasis, Mucocutaneous
Intervention: Drug: sodium stibogluconate (Pentostam)
5 Recruiting Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama
Condition: Cutaneous Leishmaniasis
Interventions: Drug: WR 279,396;   Drug: Paromomycin
6 Available Expanded Access WR 279396 Topical Cream Treatment for Uncomplicated Cutaneous Leishmaniasis
Condition: Leishmaniasis, Cutaneous
Intervention: Drug: WR 279,396
7 Recruiting Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Interventions: Drug: Meglumine antimonate;   Drug: Placebo;   Drug: Pentoxifylline
8 Not yet recruiting Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Intervention: Drug: AMBISOME
9 Recruiting WR 279,396 for the Treatment of Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Intervention: Drug: WR 279,396
10 Unknown  Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Interventions: Drug: N-metil glucamine;   Drug: Azithromycin
11 Unknown  Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine
Conditions: Visceral Leishmaniasis;   Immune Response;   Treatment
Interventions: Drug: N-acetylcysteine;   Drug: Pentavalent antimonial
12 Recruiting Comparison of Low and High Antimonial Dosage in American Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Intervention: Drug: Meglumine antimoniate
13 Recruiting Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia
Condition: Cutaneous Leishmaniasis
Intervention: Drug: Topical Amphotericin B at 3%
14 Unknown  Phase III, Study of Three Short Course Combination Regimens (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome® Alone for the Treatment of Visceral Leishmaniasis in Bangladesh
Condition: Visceral Leishmaniasis
Interventions: Drug: Liposomal amphotericin B;   Drug: liposomal amphotericin B + miltefosine;   Drug: liposomal amphotericin B + paromomycin;   Drug: Miltefosine + Paromomycin
15 Unknown  Pilot Study Using a Heat Pack to Treat Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Intervention: Device: Heat pack conduction-heat therapy
16 Not yet recruiting High Dose Fluconazole in Cutaneous Leishmaniasis in Bahia and Manaus
Condition: Cutaneous Leishmaniasis
Interventions: Drug: Fluconazole;   Drug: Meglumine Antimoniate
17 Recruiting Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in Sudan
Condition: Visceral Leishmaniasis
Intervention: Drug: Fexinidazole
18 Recruiting Pharmacokinetics of Miltefosine in Children and Adults
Condition: Cutaneous Leishmaniasis
Intervention: Drug: Miltefosine
19 Not yet recruiting Miltefosine for Children With PKDL
Condition: Post Kala Azar Dermal Leishmaniasis
Intervention: Drug: Miltefosine
20 Recruiting Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers
Condition: Visceral Leishmaniasis
Interventions: Biological: LEISH-F3 + SLA-SE;   Biological: LEISH-F3 + GLA-SE

Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results
Indicates status has not been verified in more than two years